Optimising the Use of Tazarotene in Clinical Practice: Consensus Statement from the European Advisory Panel for Tazarotene (Zorac™)

Publisher： Karger

E-ISSN： 1421-9832|199|1|40-46

ISSN： 1018-8665

Source： Dermatology, Vol.199, Iss.1, 1999-08, pp. : 40-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short Contact Therapy with Tazarotene in Psoriasis Vulgaris

By  

Dermatology, Vol. 212, Iss. 3, 2006-04 ,pp. : 235-237

Karger

Access to resources Recommend Favorite

Short-Contact Therapy with Tazarotene in Psoriasis vulgaris

By  

Dermatology, Vol. 206, Iss. 4, 2003-06 ,pp. : 347-348

Karger

Access to resources Recommend Favorite

Benefits from the Use of a Pimecrolimus-Based Treatment in the Management of Atopic Dermatitis in Clinical Practice

By  

Dermatology, Vol. 213, Iss. 4, 2006-12 ,pp. : 313-318

Karger

Access to resources Recommend Favorite

Consensus Statement on the Safety Profile of Topical Calcineurin Inhibitors

By  

Dermatology, Vol. 211, Iss. 2, 2005-08 ,pp. : 77-78

Karger

Access to resources Recommend Favorite

Clinical Use of Topical Retinaldehyde on Photoaged Skin

By  

Dermatology, Vol. 199, Iss. 1, 1999-08 ,pp. : 49-52

Karger

Access to resources Recommend Favorite